ID   EPHA4_HUMAN             Reviewed;         986 AA.
AC   P54764; Q2M380;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-NOV-2010, entry version 115.
DE   RecName: Full=Ephrin type-A receptor 4;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH-like kinase 8;
DE            Short=EK8;
DE            Short=hEK8;
DE   AltName: Full=Tyrosine-protein kinase TYRO1;
DE   AltName: Full=Tyrosine-protein kinase receptor SEK;
DE   Flags: Precursor;
GN   Name=EPHA4; Synonyms=HEK8, SEK, TYRO1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   MEDLINE=95206782; PubMed=7898931;
RA   Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M.,
RA   Basu R., Welcher A.A.;
RT   "cDNA cloning and tissue distribution of five human EPH-like receptor
RT   protein-tyrosine kinases.";
RL   Oncogene 10:897-905(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-779, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-602 AND TYR-779, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-602, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-269; GLU-370 AND PHE-399.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family. Binds to
CC       ephrin-A1, -A4 and -A5. Binds more poorly to ephrin-A2 and -A3.
CC       May play a role in a signal transduction process involved in
CC       hindbrain pattern formation.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with the src family kinase, p59-Fyn, through
CC       the major phosphorylation site at position Tyr-602. Interacts with
CC       NGEF/ephexin-1 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The protein kinase domain mediates interaction with
CC       NGEF/ephexin-1 (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36645; AAA74246.1; -; mRNA.
DR   EMBL; BC105000; AAI05001.1; -; mRNA.
DR   EMBL; BC105002; AAI05003.1; -; mRNA.
DR   IPI; IPI00008318; -.
DR   PIR; I78844; I78844.
DR   RefSeq; NP_004429.1; -.
DR   UniGene; Hs.371218; -.
DR   PDB; 2WO1; X-ray; 1.85 A; A/B=30-202.
DR   PDB; 2WO2; X-ray; 2.45 A; A=30-202.
DR   PDB; 2WO3; X-ray; 2.35 A; A=30-202.
DR   PDB; 3CKH; X-ray; 2.80 A; A/B=29-209.
DR   PDB; 3GXU; X-ray; 2.50 A; A=29-203.
DR   PDBsum; 2WO1; -.
DR   PDBsum; 2WO2; -.
DR   PDBsum; 2WO3; -.
DR   PDBsum; 3CKH; -.
DR   PDBsum; 3GXU; -.
DR   ProteinModelPortal; P54764; -.
DR   SMR; P54764; 595-904, 910-981.
DR   DIP; DIP-48294N; -.
DR   STRING; P54764; -.
DR   PhosphoSite; P54764; -.
DR   PeptideAtlas; P54764; -.
DR   PRIDE; P54764; -.
DR   Ensembl; ENST00000281821; ENSP00000281821; ENSG00000116106.
DR   Ensembl; ENST00000392071; ENSP00000375923; ENSG00000116106.
DR   Ensembl; ENST00000409938; ENSP00000386829; ENSG00000116106.
DR   GeneID; 2043; -.
DR   KEGG; hsa:2043; -.
DR   UCSC; uc002vmq.1; human.
DR   CTD; 2043; -.
DR   GeneCards; GC02M222248; -.
DR   H-InvDB; HIX0002873; -.
DR   HGNC; HGNC:3388; EPHA4.
DR   HPA; CAB004654; -.
DR   MIM; 602188; gene.
DR   PharmGKB; PA27820; -.
DR   eggNOG; prNOG17357; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P54764; -.
DR   OMA; SSKCRPC; -.
DR   OrthoDB; EOG90GG94; -.
DR   PhylomeDB; P54764; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephrina_ephapathway; EphrinA-EPHA pathway.
DR   NextBio; 8301; -.
DR   ArrayExpress; P54764; -.
DR   Bgee; P54764; -.
DR   CleanEx; HS_EPHA4; -.
DR   Genevestigator; P54764; -.
DR   GermOnline; ENSG00000116106; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR011510; SAM_2.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020768; Tyr_prot_kinase_EphA_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF278; Tyr_prot_kinase_EphA_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Repeat; Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     19       Potential.
FT   CHAIN        20    986       Ephrin type-A receptor 4.
FT                                /FTId=PRO_0000016807.
FT   TOPO_DOM     20    547       Extracellular (Potential).
FT   TRANSMEM    548    569       Helical; (Potential).
FT   TOPO_DOM    570    986       Cytoplasmic (Potential).
FT   DOMAIN      328    433       Fibronectin type-III 1.
FT   DOMAIN      441    532       Fibronectin type-III 2.
FT   DOMAIN      621    882       Protein kinase.
FT   DOMAIN      911    975       SAM.
FT   NP_BIND     627    635       ATP (By similarity).
FT   MOTIF       984    986       PDZ-binding (Potential).
FT   COMPBIAS    191    325       Cys-rich.
FT   ACT_SITE    746    746       Proton acceptor (By similarity).
FT   BINDING     653    653       ATP (By similarity).
FT   MOD_RES     596    596       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     602    602       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     779    779       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     928    928       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   CARBOHYD    235    235       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    340    340       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    408    408       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    545    545       N-linked (GlcNAc...) (Potential).
FT   VARIANT     269    269       R -> Q (in dbSNP:rs35084379).
FT                                /FTId=VAR_042135.
FT   VARIANT     370    370       G -> E (in a bladder carcinoma NOS
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042136.
FT   VARIANT     399    399       S -> F (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042137.
FT   VARIANT     953    953       R -> K (in dbSNP:rs35341687).
FT                                /FTId=VAR_049721.
FT   STRAND       31     35
FT   HELIX        36     38
FT   STRAND       46     49
FT   STRAND       55     58
FT   STRAND       68     73
FT   STRAND       76     79
FT   STRAND       82     85
FT   STRAND       96    106
FT   HELIX       108    110
FT   STRAND      120    127
FT   HELIX       139    141
FT   STRAND      142    149
FT   HELIX       163    165
FT   STRAND      167    173
FT   STRAND      182    187
FT   STRAND      191    201
SQ   SEQUENCE   986 AA;  109860 MW;  0C39C1152EDDD46F CRC64;
     MAGIFYFALF SCLFGICDAV TGSRVYPANE VTLLDSRSVQ GELGWIASPL EGGWEEVSIM
     DEKNTPIRTY QVCNVMEPSQ NNWLRTDWIT REGAQRVYIE IKFTLRDCNS LPGVMGTCKE
     TFNLYYYESD NDKERFIREN QFVKIDTIAA DESFTQVDIG DRIMKLNTEI RDVGPLSKKG
     FYLAFQDVGA CIALVSVRVF YKKCPLTVRN LAQFPDTITG ADTSSLVEVR GSCVNNSEEK
     DVPKMYCGAD GEWLVPIGNC LCNAGHEERS GECQACKIGY YKALSTDATC AKCPPHSYSV
     WEGATSCTCD RGFFRADNDA ASMPCTRPPS APLNLISNVN ETSVNLEWSS PQNTGGRQDI
     SYNVVCKKCG AGDPSKCRPC GSGVHYTPQQ NGLKTTKVSI TDLLAHTNYT FEIWAVNGVS
     KYNPNPDQSV SVTVTTNQAA PSSIALVQAK EVTRYSVALA WLEPDRPNGV ILEYEVKYYE
     KDQNERSYRI VRTAARNTDI KGLNPLTSYV FHVRARTAAG YGDFSEPLEV TTNTVPSRII
     GDGANSTVLL VSVSGSVVLV VILIAAFVIS RRRSKYSKAK QEADEEKHLN QGVRTYVDPF
     TYEDPNQAVR EFAKEIDASC IKIEKVIGVG EFGEVCSGRL KVPGKREICV AIKTLKAGYT
     DKQRRDFLSE ASIMGQFDHP NIIHLEGVVT KCKPVMIITE YMENGSLDAF LRKNDGRFTV
     IQLVGMLRGI GSGMKYLSDM SYVHRDLAAR NILVNSNLVC KVSDFGMSRV LEDDPEAAYT
     TRGGKIPIRW TAPEAIAYRK FTSASDVWSY GIVMWEVMSY GERPYWDMSN QDVIKAIEEG
     YRLPPPMDCP IALHQLMLDC WQKERSDRPK FGQIVNMLDK LIRNPNSLKR TGTESSRPNT
     ALLDPSSPEF SAVVSVGDWL QAIKMDRYKD NFTAAGYTTL EAVVHVNQED LARIGITAIT
     HQNKILSSVQ AMRTQMQQMH GRMVPV
//
